Belén García-Sagué

Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023

Eduard Brunet, Belén García-Sagué, Emili Vela, Caridad Pontes et autres

Background: The prevalence of inflammatory bowel disease (IBD) is increasing worldwide, while the incidence is tending to stabilize. Moreover, the use of biological treatments is increasing; some studies suggest that surgeries and hospitalizations are decreasing instead. Methods: A population-based, retrospective cohort study …

es (code pays fourni par la source)

Prevalence, Incidence, Mortality and Trends in Treatment of Inflammatory Bowel Disease in Catalonia Between 2017 and 2023. An Epidemiological Update

Belén García-Sagué, Emili Vela, Caridad Pontes, Luigi Melcarne et autres

Background: Prevalence of inflammatory bowel disease (IBD) is increasing worldwide, while incidence is tending to stabilize. Moreover, the use of biological treatments is increasing, some studies suggest that surgeries and hospitalizations are decreasing instead. Methods: A population-based, retrospective cohort study was conducted …

Monthly intravenous maintenance treatment with ustekinumab regains clinical response in patients with Crohn’s disease who no longer respond to the drug when administered subcutaneously

Berta López‐Sáez, Ariadna Altadill, Eduard Brunet, Belén García-Sagué et autres

Background: Several studies have assessed the efficacy of re-induction and subcutaneous intensification of ustekinumab (UST) to regain clinical remission of inflammatory bowel disease (IBD). However, very few have evaluated the effectiveness of intravenous UST for this purpose. Objectives: The aims of the …

es (code pays fourni par la source)

P-160 - IMPACTO DE LAS MANIFESTACIONES DIGESTIVAS Y NUTRICIONALES EN PACIENTES ADULTOS CON FIBROSIS QUÍSTICA E INSUFICIENCIA PANCREÁTICA EXOCRINA (IPE)

Andrea Peña-Rosado, Carla de Sárraga, Mar Salas-Llopart, Judith Cortada-Solé et autres

P-126 - PERFORACIÓN U OBSTRUCCIÓN INTESTINAL CON LA INGESTA DE CUERPOS EXTRAÑOS. ¿ES LA ENFERMEDAD DIGESTIVA SUBYACENTE UN FACTOR DE RIESGO?

Judith Cortada-Solé, Eduard Brunet, Laura‐Patricia Llovet, Belén García-Sagué et autres

P-62 - PREVALENCIA, INCIDENCIA Y MORTALIDAD DE LA ENFERMEDAD INFLAMATORIA INTESTINAL PEDIÁTRICA EN CATALUÑA

Mar Salas Llopart, Inés Loverdos, Emili Vela, Clara Comalrena de Sobregrau et autres

P-63 - TENDENCIAS TEMPORALES EN EL TRATAMIENTO Y LOS RESULTADOS DE LA ENFERMEDAD DE CROHN PEDIÁTRICA EN CATALUÑA DESDE 2021 HASTA 2023

Judith Cortada, Inés Loverdos, Emili Vera, Clara Comalrena de Sobregrau et autres

P895 Analysis of the efficacy of intravenous ustekinumab maintenance treatment in patients with refractory Inflammatory Bowel Disease

Berta López‐Sáez, Eduard Brunet, Luigi Melcarne, A Puy et autres

Abstract Background Ustekinumab (UST) is a monoclonal antibody that inhibits the p40 subunit of IL-12 and IL-23, approved for the treatment of Crohn's Disease (CD) and Ulcerative Colitis (UC). Its administration is intravenous during induction and subcutaneous during maintenance. Several studies have …

es (code pays fourni par la source)

P647 Effectiveness of combined treatment with two biologics or advanced molecules in inflammatory bowel disease

Luigi Melcarne, Isabel Laucirica, Albert Villòria, A Puy et autres

Abstract Background Treatment with a combination of biologic drugs or advanced molecules represents a seldom-used therapeutic option for inflammatory bowel disease (IBD). Data on the effectiveness of these combinations of treatment are limited. The objective of this study is to assess the …

es (code pays fourni par la source)

Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis

Eduard Brunet, Belén García-Sagué, Emili Vela, Luigi Melcarne et autres

Background: Inflammatory bowel disease (IBD) has a major economic impact on healthcare costs. Objectives: The aim of this study was to evaluate the current healthcare expenditure associated with IBD in a population-wide study in Catalonia. Design: Retrospective observational study. Methods: All patients …

es, dk, ca (code pays fourni par la source)

Development and validation of the inflammatory bowel disease objective disability index (IBDODI)

Luigi Melcarne, Eduard Brunet, Albert Villòria, Mercedes Vergara et autres

Abstract Introduction Many scores aiming to measure Inflammatory bowel disease (IBD)-related disability have been validated. However, they rely mostly on patients’ subjective perceptions, and may, therefore, be biased by them. To obtain a more objective measure of disability, the present study aimed …

es (code pays fourni par la source)

Local endoscopic pancreatic necrosectomy vs international endoscopic pancreatic necrosectomy: A real life quality control study

Félix Junquera, Salvador Machlab, Mireia Miquel, Valentí Puig‐Diví et autres

Aims Endoscopic pancreatic necrosectomy (EPN) is the standard of care for symptomatic walled off necrosis. EPN is a complex procedure consisting of an EUS guided necrosis pancreatic drainage, usually using luminal apposing metal stents (LAMS), and its extraction to the digestive tract. …

es (code pays fourni par la source)